UCB predicts profit hit on Keppra generics; Roche's RoActemra shines in RA study;

@FiercePharma: China pharmaceuticals feel bite of healthcare reforms. Story via @Reuters | Follow @FiercePharma

> Belgium's UCB has predicted revenue and profit will fall this year as generic competition hits its epilepsy blockbuster Keppra. News

> Preliminary results from a study of Roche's ($RHHBY) RoActemra (aka Actemra) as a monotherapy for rheumatoid arthritis showed that the med significantly reduced disease activity after 24 weeks when evaluated against adalimumab monotherapy. Roche release

> The FDA says it is evaluating Propecia, Merck's ($MRK) hair growth drug, in a new safety review. "The focus of the current review is the persistence of severe male sexual dysfunction after discontinuation of Propecia's use," the FDA's Sandy Walsh said in an email message to the Examiner. "This review was prompted by routine drug safety surveillance." Item

> Baxter International ($BAX) has received marketing authorization from the European Commission for Vepacel, a pre-pandemic influenza vaccine indicated for active immunization in adults. Baxter release

>  Merck KGaA is donating equipment for detecting counterfeit drugs to Zambian officials. Interpol estimates that up to 30% of all medicines in Africa are either counterfeit or of inferior quality. Report

Biotech News

@FierceBiotech: NIH backs effort to integrate clinical trials data into EHRs. Story | Follow @FierceBiotech

@JohnCFierce: ACT's trying a reverse split in the range of 1/20, 1/80 to get onto Nasdaq. Often hyped but interesting stem cell work. Release | Follow @JohnCFierce

@RyanMFierce: Worth the 5 mins to read @ldtimmerman 's interview with former Amgen R&D chief Roger Perlmutter. Interview | Follow @RyanMFierce

@FierceMedDev: Cipla introduces new pain-free screening tech for early detection of breast cancer in India. Story | Follow @FierceMedDev

> Columbia Labs axing 42% of jobs after FDA shoots down drug application. News

> Novartis cancer drugs stymie deadly Ebola virus. Report

And Finally... A new study has found that women who remain seated for long periods of time every day are more prone to developing Type 2 diabetes. However, men may not face the same risk. Release

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.